Orphan Drug Designation applies to approximately 50,000 Patients who predominantly suffer from severe chronic pain due ...
Researchers at Leipzig University and TU Dresden have succeeded in developing biological switches that can selectively turn ion channels on and off using light pulses. Initial applications show that ...
Nocion Therapeutics, Inc. a biopharmaceutical company developing novel small molecule therapies that selectively silence activated sensory neurons, today announced that preclinical data supporting the ...
Nocion Therapeutics, Inc. a biopharmaceutical company developing novel small molecule therapies that selectively silence ...
HUICHENG DISTRICT, HUIZHOU CITY, GUANGDONG PROVINCE, CHINA, January 16, 2026 /EINPresswire.com/ -- The global market ...
Home > Pressemitteilung: Stimulating biological processes with ...
ARTBIO, Inc. ("ARTBIO"), a clinical-stage radiopharmaceutical company developing a new class of 212Pb alpha radioligand therapies (ARTs), today commenced dosing of two cohorts in the U.S. as part of ...
13don MSN
Brain navigation study reveals function of an unconventional electrical-signaling mode in neurons
Navigating the world is no mean feat, especially when the world pushes back. For instance, airflow hitting a fly on its right ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results